EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent

Magdalena Ostaszewska, Milena Majchrzyk, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Weronika Walendziak, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Anna Malczyk

Quality in Sport · 05.04.2026 · 54 · 70302

DOI: 10.12775/qs.2026.54.70302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 05.04.2026. Verfasst von Magdalena Ostaszewska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aim of the study: 3,4-methylenedioxymethamphetamine (MDMA) is a stimulant drug with widespread consumption. It is used mainly in recreational settings, due to its ability to induce various pleasurable, mood-enhancing effects. Prolonged and excessive MDMA misuse can lead to multiple negative outcomes ranging from cognitive dysfunction or emotional dysregulation to severe life-threatening consequences such as hyperthermia. Despite its harmful potential, MDMA presents promising therapeutic applications in MDMA-Assisted Therapy. In this study we aim to review both the dangers and potential psychiatric applications of MDMA. Materials and methods: A literature search was conducted using databases such as PubMed and Google Scholar. The review focused on peer-reviewed articles and international reports regarding the use of MDMA, both recreational and in the treatment of various psychiatric conditions. Conclusions: While MDMA has traditionally been associated mainly with recreational use and addiction, research suggests it has the potential to become a valuable therapeutic adjunct in treating such psychiatric conditions as PTSD, alcohol dependence, depression and anxiety. Furthermore, it could be beneficial in the athletic populations. However, existing studies are limited by small sample sizes, highlighting the need for further large-scale research to confirm these findings.Keywords: MDMA, MDMA-Assisted Therapy, PTSD, alcohol dependence, depression, anxiety, mental health of athletic populations

Zitieren

APA

Ostaszewska, M., Majchrzyk, M., Zienkiewicz, D., Makulec, G., Domosud, K., Walendziak, W., Mordal, N., Ściebura, K., Wiśniewska, W., & Malczyk, A. (2026). 3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent. Quality in Sport, 54, 70302. https://doi.org/10.12775/qs.2026.54.70302

Vancouver

Ostaszewska M, Majchrzyk M, Zienkiewicz D, Makulec G, Domosud K, Walendziak W, et al. 3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent. Quality in Sport. 2026;54:70302. doi:10.12775/qs.2026.54.70302

BibTeX
@article{Ostaszewska2026,
  author = {Ostaszewska, Magdalena and Majchrzyk, Milena and Zienkiewicz, Damian and Makulec, Gabriela and Domosud, Karolina and Walendziak, Weronika and Mordal, Natalia and Ściebura, Kacper and Wiśniewska, Wiktoria and Malczyk, Anna},
  title = {3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent},
  journal = {Quality in Sport},
  year = {2026},
  volume = {54},
  pages = {70302},
  doi = {10.12775/qs.2026.54.70302}
}
Kostenlos starten →